{"id":93,"date":"2025-09-17T18:10:27","date_gmt":"2025-09-17T16:10:27","guid":{"rendered":"https:\/\/bicconference.org\/2025\/?page_id=93"},"modified":"2026-11-11T10:16:48","modified_gmt":"2026-11-11T09:16:48","slug":"programme-13","status":"publish","type":"page","link":"https:\/\/bicconference.org\/2025\/programme-13\/","title":{"rendered":"Programme 13"},"content":{"rendered":"<div class=\"et_pb_section_0 et_pb_section et_section_regular et_block_section\">\n<div class=\"et_pb_row_0 et_pb_row et_block_row titoli\">\n<div class=\"et_pb_column_0 et_pb_column et_pb_column_4_4 et-last-child et_block_column et_pb_css_mix_blend_mode_passthrough\">\n<div class=\"et_pb_text_0 et_pb_text et_pb_bg_layout_light et_pb_module et_block_module\"><div class=\"et_pb_text_inner\"><p>Programme<\/p>\n<\/div><\/div>\n<\/div>\n<\/div>\n\n<div class=\"et_pb_row_1 et_pb_row et_block_row\">\n<div class=\"et_pb_column_1 et_pb_column et_pb_column_1_3 et_block_column et_pb_css_mix_blend_mode_passthrough\">\n<div class=\"et_pb_code_0 et_pb_code et_pb_module\"><div class=\"et_pb_code_inner\"><a href=\"..\/programme-12\">\n<div class=\"PRbott off\">FRIDAY<br \/><strong>12th SEPTEMBER<\/strong><\/div>\n<\/a><\/div><\/div>\n<\/div>\n\n<div class=\"et_pb_column_2 et_pb_column et_pb_column_1_3 et_block_column et_pb_css_mix_blend_mode_passthrough\">\n<div class=\"et_pb_code_1 et_pb_code et_pb_module\"><div class=\"et_pb_code_inner\"><a href=\"..\/programme-13\">\n<div class=\"PRbott on\">SATURDAY<br \/><strong>13th SEPTEMBER<\/strong><\/div>\n<\/a><\/div><\/div>\n<\/div>\n\n<div class=\"et_pb_column_3 et_pb_column et_pb_column_1_3 et-last-child et_block_column et_pb_css_mix_blend_mode_passthrough\">\n<div class=\"et_pb_code_2 et_pb_code et_pb_module\"><div class=\"et_pb_code_inner\"><a href=\"..\/programme-14\">\n<div class=\"PRbott off\">SUNDAY<br \/><strong>14th SEPTEMBER<\/strong><\/div>\n<\/a><\/div><\/div>\n<\/div>\n<\/div>\n\n<div class=\"et_pb_row_2 et_pb_row et_block_row\">\n<div class=\"et_pb_column_4 et_pb_column et_pb_column_2_5 et_block_column et_pb_css_mix_blend_mode_passthrough PRleft\">\n<div class=\"et_pb_text_1 et_pb_text et_pb_bg_layout_light et_pb_module et_block_module\"><div class=\"et_pb_text_inner\"><p class=\"titoloSES Sscientific\">GENE THERAPY<\/p>\n<p><em><strong>Chairs:<\/strong> Wolfgang Miesbach (Germany), Glenn Pierce (USA)<\/em><\/p>\n<\/div><\/div>\n<\/div>\n\n<div class=\"et_pb_column_5 et_pb_column et_pb_column_3_5 et-last-child et_block_column et_pb_css_mix_blend_mode_passthrough\">\n<div class=\"et_pb_text_2 et_pb_text et_pb_bg_layout_light et_pb_module et_block_module\"><div class=\"et_pb_text_inner\"><p class=\"PRorari\">09:00-09:20<\/p>\n<p class=\"PRtesto scientific\"><strong>Efficacy and safety of gene therapy with AAV<\/strong><br \/>\n<em>Paul Batty (UK)<\/em><\/p>\n<p class=\"PRorari\">09:20-09:40<\/p>\n<p class=\"PRtesto scientific\"><strong>Where we are with lentiviral vectors in bleeding disorders<\/strong><br \/>\n<em>Alessio Cantore (Italy)<\/em><\/p>\n<p class=\"PRorari\">09:40-10:00<\/p>\n<p class=\"PRtesto scientific\"><strong>Liver health and AAV gene therapy<\/strong><br \/>\n<em>Vincenzo La Mura (Italy)<\/em><\/p>\n<p class=\"PRorari\">10:00-10:20<\/p>\n<p class=\"PRtesto scientific\"><strong>Immune tolerance induction by gene therapy<\/strong><br \/>\n<em>Roland Herzog (USA)<\/em><\/p>\n<p class=\"PRorari\">10:20-10:35<\/p>\n<p class=\"PRtesto scientific\"><strong>Discussion<\/strong><\/p>\n<\/div><\/div>\n<\/div>\n<\/div>\n\n<div class=\"et_pb_row_3 et_pb_row et_block_row\">\n<div class=\"et_pb_column_6 et_pb_column et_pb_column_2_5 et_block_column et_pb_column_empty et_pb_css_mix_blend_mode_passthrough PRleft\"><\/div>\n\n<div class=\"et_pb_column_7 et_pb_column et_pb_column_3_5 et-last-child et_block_column et_pb_css_mix_blend_mode_passthrough\">\n<div class=\"et_pb_text_3 et_pb_text et_pb_bg_layout_light et_pb_module et_block_module\"><div class=\"et_pb_text_inner\"><p class=\"PRorari\">10:35-11:05<\/p>\n<p class=\"PRtesto break\">Coffee break<\/p>\n<\/div><\/div>\n<\/div>\n<\/div>\n\n<div class=\"et_pb_row_4 et_pb_row et_block_row\">\n<div class=\"et_pb_column_8 et_pb_column et_pb_column_2_5 et_block_column et_pb_column_empty et_pb_css_mix_blend_mode_passthrough PRleft\"><\/div>\n\n<div class=\"et_pb_column_9 et_pb_column et_pb_column_3_5 et-last-child et_block_column et_pb_css_mix_blend_mode_passthrough\">\n<div class=\"et_pb_text_4 et_pb_text et_pb_bg_layout_light et_pb_module et_block_module\"><div class=\"et_pb_text_inner\"><p class=\"PRorari\">11:05-11:25<\/p>\n<p class=\"PRtesto scientific\"><strong>The prospects of genome editing to treat inherited coagulation disorders<\/strong><br \/>\n<em>Gregory Newby (USA)<\/em><\/p>\n<p class=\"PRorari\">11:25-11:45<\/p>\n<p class=\"PRtesto scientific\"><strong>Gene therapy in factor VII deficiency and long term data on FIX deficiency with AAV<\/strong><br \/>\n<em>Amit Nathwani (UK)<\/em><\/p>\n<p class=\"PRorari\">11:45-12:00<\/p>\n<p class=\"PRtesto scientific\"><strong>Discussion<\/strong><\/p>\n<\/div><\/div>\n<\/div>\n<\/div>\n\n<div class=\"et_pb_row_5 et_pb_row et_block_row\">\n<div class=\"et_pb_column_10 et_pb_column et_pb_column_2_5 et_block_column et_pb_css_mix_blend_mode_passthrough PRleft\">\n<div class=\"et_pb_text_5 et_pb_text et_pb_bg_layout_light et_pb_module et_block_module\"><div class=\"et_pb_text_inner\"><p class=\"titoloSES Ssatellite\">SATELLITE SYMPOSIUM<\/p>\n<\/div><\/div>\n<\/div>\n\n<div class=\"et_pb_column_11 et_pb_column et_pb_column_3_5 et-last-child et_block_column et_pb_css_mix_blend_mode_passthrough\">\n<div class=\"et_pb_text_6 et_pb_text et_pb_bg_layout_light et_pb_module et_block_module\"><div class=\"et_pb_text_inner\"><p class=\"PRorari\">12:00-13:00<\/p>\n<p class=\"PRtesto satellite\"><strong>Sponsored by Octapharma<\/strong><br \/>\n<a href=\"https:\/\/bicconference.org\/2025\/programme-satellite-4\/\">PROGRAMME<\/a><\/p>\n<\/div><\/div>\n<\/div>\n<\/div>\n\n<div class=\"et_pb_row_6 et_pb_row et_block_row\">\n<div class=\"et_pb_column_12 et_pb_column et_pb_column_2_5 et_block_column et_pb_column_empty et_pb_css_mix_blend_mode_passthrough PRleft\"><\/div>\n\n<div class=\"et_pb_column_13 et_pb_column et_pb_column_3_5 et-last-child et_block_column et_pb_css_mix_blend_mode_passthrough\">\n<div class=\"et_pb_text_7 et_pb_text et_pb_bg_layout_light et_pb_module et_block_module\"><div class=\"et_pb_text_inner\"><p class=\"PRorari\">13:00-14:00<\/p>\n<p class=\"PRtesto break\">Lunch<\/p>\n<\/div><\/div>\n<\/div>\n<\/div>\n\n<div class=\"et_pb_row_7 et_pb_row et_block_row\">\n<div class=\"et_pb_column_14 et_pb_column et_pb_column_2_5 et_block_column et_pb_css_mix_blend_mode_passthrough PRleft\">\n<div class=\"et_pb_text_8 et_pb_text et_pb_bg_layout_light et_pb_module et_block_module\"><div class=\"et_pb_text_inner\"><p class=\"titoloSES Ssatellite\">SATELLITE SYMPOSIUM<\/p>\n<\/div><\/div>\n<\/div>\n\n<div class=\"et_pb_column_15 et_pb_column et_pb_column_3_5 et-last-child et_block_column et_pb_css_mix_blend_mode_passthrough\">\n<div class=\"et_pb_text_9 et_pb_text et_pb_bg_layout_light et_pb_module et_block_module\"><div class=\"et_pb_text_inner\"><p class=\"PRorari\">14:00-15:00<\/p>\n<p class=\"PRtesto satellite\"><strong>Sponsored by Takeda<\/strong><br \/>\n<a href=\"https:\/\/bicconference.org\/2025\/programme-satellite-5\/\">PROGRAMME<\/a><\/p>\n<\/div><\/div>\n<\/div>\n<\/div>\n\n<div class=\"et_pb_row_8 et_pb_row et_block_row\">\n<div class=\"et_pb_column_16 et_pb_column et_pb_column_2_5 et_block_column et_pb_css_mix_blend_mode_passthrough PRleft\">\n<div class=\"et_pb_text_10 et_pb_text et_pb_bg_layout_light et_pb_module et_block_module\"><div class=\"et_pb_text_inner\"><p class=\"titoloSES Soral\">ORAL COMMUNICATIONS<\/p>\n<p><em><strong>Chairs:<\/strong> Augusto B. Federici (Italy), Riitta Lassila (Finland)<\/em><\/p>\n<\/div><\/div>\n<\/div>\n\n<div class=\"et_pb_column_17 et_pb_column et_pb_column_3_5 et-last-child et_block_column et_pb_css_mix_blend_mode_passthrough\">\n<div class=\"et_pb_text_11 et_pb_text et_pb_bg_layout_light et_pb_module et_block_module\"><div class=\"et_pb_text_inner\"><p class=\"PRorari\">15:00-15:10<\/p>\n<p class=\"PRtesto oral\"><strong>Comparison of a newly-formulated DDAVP to Stimate in persons with type 1 von Willebrand disease<\/strong><br \/>\n<em>Amy Shapiro (USA)<\/em><\/p>\n<p class=\"PRorari\">15:10-15:20<\/p>\n<p class=\"PRtesto oral\"><strong>Lentiviral vector-based innovative gene therapy approaches for hemophilia A<\/strong><br \/>\n<em>Michela Milani (Italy)<\/em><\/p>\n<p class=\"PRorari\">15:20-15:30<\/p>\n<p class=\"PRtesto oral\"><strong>Phase I study of VGA039 in individuals with von Willebrand disease demonstrates sustained drug concentrations, increased thrombin generation, and decreased bleeding after single subcutaneous injection<\/strong><br \/>\n<em>Carolyn Millar (UK)<\/em><\/p>\n<p class=\"PRorari\">15:30-15:40<\/p>\n<p class=\"PRtesto oral\"><strong>Safety and efficacy of valoctocogene roxaparvovec in participants with active or prior FVIII inhibitors: Results from a phase 1\/2 trial<\/strong><br \/>\n<em>Konstantia-Maria Chavele (UK)<\/em><\/p>\n<p class=\"PRorari\">15:40-15:50<\/p>\n<p class=\"PRtesto oral\"><strong>Targeting antigen-specific B cells in iTTP using modular CAR T cells<\/strong><br \/>\n<em>Sara Rovira Puig (Belgium)<\/em><\/p>\n<p class=\"PRorari\">15:50-16:00<\/p>\n<p class=\"PRtesto oral\"><strong>Efficacy and safety update of giroctocogene fitelparvovec in adults with moderately severe to severe hemophilia A: results from the phase 3 AFFINE gene therapy trial<\/strong><br \/>\n<em>Davide Matino (Canada)<\/em><\/p>\n<\/div><\/div>\n<\/div>\n<\/div>\n\n<div class=\"et_pb_row_9 et_pb_row et_block_row\">\n<div class=\"et_pb_column_18 et_pb_column et_pb_column_2_5 et_block_column et_pb_column_empty et_pb_css_mix_blend_mode_passthrough PRleft\"><\/div>\n\n<div class=\"et_pb_column_19 et_pb_column et_pb_column_3_5 et-last-child et_block_column et_pb_css_mix_blend_mode_passthrough\">\n<div class=\"et_pb_text_12 et_pb_text et_pb_bg_layout_light et_pb_module et_block_module\"><div class=\"et_pb_text_inner\"><p class=\"PRorari\">16:00-16:30<\/p>\n<p class=\"PRtesto break\">Coffee break<\/p>\n<\/div><\/div>\n<\/div>\n<\/div>\n\n<div class=\"et_pb_row_10 et_pb_row et_block_row\">\n<div class=\"et_pb_column_20 et_pb_column et_pb_column_2_5 et_block_column et_pb_css_mix_blend_mode_passthrough PRleft\">\n<div class=\"et_pb_text_13 et_pb_text et_pb_bg_layout_light et_pb_module et_block_module\"><div class=\"et_pb_text_inner\"><p class=\"titoloSES Sscientific\">VWD \u2013 CLINICAL SESSION<\/p>\n<p><em><strong>Chairs:<\/strong> Giancarlo Castaman (Italy), C\u00e9cile Denis (France)<\/em><\/p>\n<\/div><\/div>\n<\/div>\n\n<div class=\"et_pb_column_21 et_pb_column et_pb_column_3_5 et-last-child et_block_column et_pb_css_mix_blend_mode_passthrough\">\n<div class=\"et_pb_text_14 et_pb_text et_pb_bg_layout_light et_pb_module et_block_module\"><div class=\"et_pb_text_inner\"><p class=\"PRorari\">16:30-16:50<\/p>\n<p class=\"PRtesto scientific\"><strong>DDAVP in VWD: how to predict the response<\/strong><br \/>\n<em>Frank Leebeek (the Netherlands)<\/em><\/p>\n<p class=\"PRorari\">16:50-17:10<\/p>\n<p class=\"PRtesto scientific\"><strong>Personalized prophylaxis for VWD<\/strong><br \/>\n<em>David Lillicrap (Kingston, ON, Canada)<\/em><\/p>\n<p class=\"PRorari\">17:10-17:30<\/p>\n<p class=\"PRtesto scientific\"><strong>Type 1 VWD: do they bleed? How can we assess their bleeding tendency?<\/strong><br \/>\n<em>Omid Seidizadeh (Italy)<\/em><\/p>\n<p class=\"PRorari\">17:30-17:45<\/p>\n<p class=\"PRtesto scientific\"><strong>Discussion<\/strong><\/p>\n<\/div><\/div>\n<\/div>\n<\/div>\n\n<div class=\"et_pb_row_11 et_pb_row et_block_row\">\n<div class=\"et_pb_column_22 et_pb_column et_pb_column_2_5 et_block_column et_pb_column_empty et_pb_css_mix_blend_mode_passthrough PRleft\"><\/div>\n\n<div class=\"et_pb_column_23 et_pb_column et_pb_column_3_5 et-last-child et_block_column et_pb_css_mix_blend_mode_passthrough\">\n<div class=\"et_pb_text_15 et_pb_text et_pb_bg_layout_light et_pb_module et_block_module\"><div class=\"et_pb_text_inner\"><p class=\"PRorari\">17:45-18:45<\/p>\n<p class=\"PRtesto oral\"><strong>E-POSTER SESSION<\/strong><br \/>\n<a href=\"https:\/\/bicconference.org\/2025\/img\/BIC2025_eposter_programme.pdf\">PROGRAMME<\/a><\/p>\n<\/div><\/div>\n<\/div>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-93","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/bicconference.org\/2025\/wp-json\/wp\/v2\/pages\/93","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bicconference.org\/2025\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/bicconference.org\/2025\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/bicconference.org\/2025\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bicconference.org\/2025\/wp-json\/wp\/v2\/comments?post=93"}],"version-history":[{"count":4,"href":"https:\/\/bicconference.org\/2025\/wp-json\/wp\/v2\/pages\/93\/revisions"}],"predecessor-version":[{"id":201,"href":"https:\/\/bicconference.org\/2025\/wp-json\/wp\/v2\/pages\/93\/revisions\/201"}],"wp:attachment":[{"href":"https:\/\/bicconference.org\/2025\/wp-json\/wp\/v2\/media?parent=93"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}